0001062993-18-001883.txt : 20180502 0001062993-18-001883.hdr.sgml : 20180502 20180502124036 ACCESSION NUMBER: 0001062993-18-001883 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180502 DATE AS OF CHANGE: 20180502 EFFECTIVENESS DATE: 20180502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Xanthic Biopharma Inc. CENTRAL INDEX KEY: 0001739376 IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-311493 FILM NUMBER: 18798578 BUSINESS ADDRESS: STREET 1: 2100 BLOOR ST. WEST, SUITE 6339 CITY: TORONTO STATE: A6 ZIP: M6S 5A5 BUSINESS PHONE: 647-341-8033 MAIL ADDRESS: STREET 1: 2100 BLOOR ST. WEST, SUITE 6339 CITY: TORONTO STATE: A6 ZIP: M6S 5A5 D 1 primary_doc.xml X0708 D LIVE 0001739376 Xanthic Biopharma Inc. 2100 BLOOR ST. WEST, SUITE 6339 TORONTO A6 ONTARIO, CANADA M6S 5A5 647-341-8033 ONTARIO, CANADA Aurquest Resources Inc. None Corporation true David Bhumgara 2100 Bloor St. West, Suite 6339 Toronto A6 ONTARIO, CANADA M6S 5A5 Executive Officer Tim Moore 2100 Bloor St. West, Suite 6339 Toronto A6 ONTARIO, CANADA M6S 5A5 Executive Officer Director Gary Galitsky 2100 Bloor St. West, Suite 6339 TORONTO A6 ONTARIO, CANADA M6S 5A5 Executive Officer Director Dr. Shafik Dharamshi 2100 Bloor St. West, Suite 6339 TORONTO A6 ONTARIO, CANADA M6S 5A5 Director Dr. Gunter Hintz 2100 Bloor St. West, Suite 6339 TORONTO A6 ONTARIO, CANADA M6S 5A5 Director Carli Posner 2100 Bloor St. West, Suite 6339 TORONTO A6 ONTARIO, CANADA M6S 5A5 Director David Lubotta 2100 Bloor St. West, Suite 6339 Toronto A6 ONTARIO, CANADA M6S 5A5 Director Peter Schwartz 2100 Bloor St. West, Suite 6339 Toronto A6 ONTARIO, CANADA M6S 5A5 Director Other Decline to Disclose 06b false 2018-04-19 false true true true true Units consisting of 1 cmn share & 1/2 cmn share purchase warrant, each whole warrant is exercisable for CAD$0.75 per share for 24 months post closing. false 0 34632 19790 14842 Units consisting of 1 cmn share & 1/2 cmn share purchase warrant, each whole warrant is exercisable for CAD $0.75 per share for 24 months post closing. false 1 0 0 0 false Xanthic Biopharma Inc. /s/ David Bhumgara David Bhumgara Chief Financial Officer 2018-04-30